CRDMO Boom Explained 📈 | Laurus Labs vs Divi’s Laboratories

https://indmoney.onelink.me/RmHC/xaq52zht

India’s CRDMO (Contract Research, Development & Manufacturing) sector is entering a massive growth phase and is expected to reach ~$25 billion by 2035 📈

In this video, we do a detailed comparison of Laurus Labs and Divi’s Laboratories, two key players benefiting from this pharma outsourcing boom.

🔍 What you’ll learn:

✅ What is CRDMO & why it’s growing fast
✅ Laurus Labs’ integrated pharma & growth strategy
✅ Divi’s Laboratories’ strength in complex chemical synthesis
✅ Revenue growth vs operating margin comparison
✅ Profit efficiency: why Divi’s margins are almost 2× higher
✅ Valuation risk: high P/S multiples explained
✅ Which stock looks better for long-term investors?

⚠️ While both companies are operationally strong, premium valuations and margin volatility are key risks investors must carefully evaluate.

📊 Watch till the end to decide which pharma stock fits your risk profile better.

Видео CRDMO Boom Explained 📈 | Laurus Labs vs Divi’s Laboratories канала OneApp Investor With Raj